Specify a stock or a cryptocurrency in the search bar to get a summary
Krka d. d
KRKKrka, d. d., a generic pharmaceutical company, develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and internationally. Its prescription pharmaceuticals include medicines for the treatment of cardiovascular, alimentary tract and metabolism, central nervous system, infections, oncology, and other diseases. The company also provides non-prescription products for oral cavity and pharynx; cough and cold; analgesics; nasal products; vitamin and mineral products; products for enhancing cerebral and peripheral circulation; products for enhancing digestive tract and digestion; health care products; and others. In addition, it offers animal health products comprising analgesics antimicrobials, antiparasitics, disinfectants, vitamins, and minerals. Further, the company provides health resort and tourist services. Krka, d. d. was founded in 1954 and is headquartered in Novo Mesto, Slovenia. Address: ?marje?ka cesta 6, Novo Mesto, Slovenia, 8501
Analytics
WallStreet Target Price
436.85 PLNP/E ratio
11.3897Dividend Yield
5.6 %Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures KRK
Dividend Analytics KRK
Dividend growth over 5 years
136 %Continuous growth
6 yearsPayout Ratio 5 years average
54 %Dividend History KRK
Stock Valuation KRK
Financials KRK
Results | 2019 | Dynamics |